A study involving Columbia researchers finds that malaria parasites in Africa have developed resistance to artemisinin drugs, which could worsen malaria’s impact if partner drugs fail in the future.
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Now in its fifth year, the center has built close relationships with members of the Harlem and Washington Heights communities. Those relationships were pivotal when COVID-19 arrived.
Columbia clinical microbiologist Gregory Berry, PhD, explains what rapid at-home tests can—and cannot—do to help keep us and those around us safe from COVID.
The new Pandemic Response Institute draws heavily on ICAP’s strength in building partnerships and will help New York City equitably detect, respond to, and recover from major health emergencies.
After infection with the COVID virus, where does the immune system store the memory? A new study finds memory cells take up residence in the lung to protect against reinfection.
With an award from New York City Economic Development Corporation, Columbia—through its Mailman School of Public Health—and a consortium will launch NYC’s first Pandemic Response Institute.
Kidney transplant recipients and those waiting for a transplant face a high risk of dying from COVID, with patients from racial and ethnic minorities at greater risk.
City neighborhoods with the highest COVID vaccination rates had lower historical COVID death rates, showing that lifesaving vaccines have been slow to reach the pandemic's hardest-hit areas.